Richard Nolan Townsend insider trades: Lexeo Therapeutics (LXEO) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Richard reports to the SEC
Open-market buys and sales
18 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 18, 2026 | LXEO | ↓ Sell | 3,345 | $4.95 | $17K | Direct | Aug 19, 2026 (1d) |
| Jul 1, 2026 | LXEO | ↓ Sell | 25,947 | $4.48 | $116K | Direct | Jul 1, 2026 (0d) |
| May 18, 2026 | LXEO | ↓ Sell | 3,342 | $5.06 | $17K | Direct | May 20, 2026 (2d) |
| Apr 6, 2026 | LXEO | ↓ Sell | 55,000 | $5.69 | $313K | Direct | Apr 7, 2026 (1d) |
| Feb 18, 2026 | LXEO | ↓ Sell | 10,173 | $6.38 | $65K | Direct | Feb 20, 2026 (2d) |
| Nov 18, 2025 | LXEO | ↓ Sell | 1,127 | $9.27 | $10K | Direct | Nov 20, 2025 (2d) |
| Oct 17, 2025 | LXEO | ↓ Sell | 13,133 | $8.94 | $117K | Direct | Oct 17, 2025 (0d) |
| Aug 18, 2025 | LXEO | ↓ Sell | 2,735 | $4.67 | $13K | Direct | Aug 20, 2025 (2d) |
| May 16, 2025 | LXEO | ↓ Sell | 1,074 | $2.77 | $3K | Direct | May 20, 2025 (4d) |
| Feb 19, 2025 | LXEO | ↓ Sell | 4,326 | $4.41 | $19K | Direct | Feb 21, 2025 (2d) |
| Dec 10, 2024 | LXEO | ↓ Sell | 2,500 | $8.20 | $20K | Direct | Dec 12, 2024 (2d) |
| Nov 11, 2024 | LXEO | ↓ Sell | 2,500 | $7.82 | $20K | Direct | Nov 13, 2024 (2d) |
| Oct 10, 2024 | LXEO | ↓ Sell | 5,000 | $8.10 | $40K | Direct | Oct 15, 2024 (5d) |
| Sep 10, 2024 | LXEO | ↓ Sell | 5,000 | $10.65 | $53K | Direct | Sep 11, 2024 (1d) |
| Aug 12, 2024 | LXEO | ↓ Sell | 5,000 | $11.53 | $58K | Direct | Aug 13, 2024 (1d) |
| Jul 11, 2024 | LXEO | ↓ Sell | 55,000 | $16.79 | $923K | Direct | Jul 12, 2024 (1d) |
| Jun 10, 2024 | LXEO | ↓ Sell | 5,000 | $17.65 | $88K | Direct | Jun 12, 2024 (2d) |
| May 13, 2024 | LXEO | ↓ Sell | 5,000 | $13.22 | $66K | Direct | May 14, 2024 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other LXEO insiders
Open-market trades in the last 12 months
About Richard Nolan Townsend's insider trades
Richard Nolan Townsend is Chief Executive Officer at Lexeo Therapeutics (LXEO). Since May 13, 2024, Richard has reported no open-market purchases and 18 sales worth $2.0M on SEC Form 4. In the last 12 months: 6 sales ($538K).
Their filings also include grants and awards (9 filings), option exercises (8 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every LXEO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.